Radiation Therapy Market Size, Growth, Demands Outlook and Forecasts to 2030

 According to the research report, the global radiationtherapy market size is expected to touch USD 13.2 Billion by 2030, from USD 6.8 Billion in 2021, growing with a significant CAGR of 7.65% from 2022 to 2030. 

The radiation therapy market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global radiation therapy market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global radiation therapy market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global radiation therapy market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link https://www.precedenceresearch.com/sample/2272

 Report Scope of the Radiation Therapy Market

Report Coverage	Details
Market Size in 2022	USD 7.32 Billion
Market Size by 2030	USD 13.2 Billion
Growth Rate from 2022 to 2030	CAGR of 7.65%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Type, Technology, Application, Procedure, End-User, and Geography

This study covers a detailed segmentation of the global radiation therapy market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global radiation therapy market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players are Nordion Inc, Siemens healthcare, Mevion medical system, Inc, Isoray, Inc, Icad, Inc, Becton Dickinson and Company, Ion Beam Appications SA, Elekta AB, Eckert & Zeigler Group, Accuray, Incorporated, Varian Medical Syatems, Inc, NTP Radioisotopes SOC Ltd, Curium Pharma, C.R.BARD, Inc, IBA Radiopharma Solutions, ViewRay, Inc, P-cure Ltd, ZEISS Group, Panacea Medical Technologies, Hitachi Ltd

Market Segmentation

 By Type

• Product
• Service

By Technology

• External Beam Radiotherapy
  • Linear accelerators
    • Convential linear accelerators 
    • Stereotactic advanced Elecron/Cobalt-60-linear accelerators 
    • Gamma Knife
    • CyberKnife
    • Tomotherapy
• Convnetial Cobalt-60 Teletherapy Units
• Particle Therapy Systems
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotron
• Internal Beam Radiotherapy/Brachytherapy
  • Seeds
  • Afterloaders
  • Applicators
  • IORT Systems
• Systemic Radiotherapy
  • Lobenguane (I-131)
  • Samarium-153
  • Rhenium- 186
  • Others

By Application

• External Beam Radiotherapy
  • Prostate cancer
  • Breast cancer
  • Lung cancer
  • Head and neck cancer
  • Colorectal cancer
  • Others
• Internal Beam Radiotherapy/Brachytherapy
  • Prostate cancer
  • Gynecological cancer
  • Breast cancer
  • Cervical cancer
  • Penile cancer
  • Others

By Procedure

• External Beam Radiotherapy
  • Image guided radiotherapy
  • Intensity-modulated radiotherapy
  • Stereotactic therapy
  • Particle therapy
  • 3D Conformal radiotherapy
• Internal Beam Radiotherapy/Brachytherapy
  • High-dose-rate Brachytherapy
  • Low-dose-rate Brachytherapy
  • Pulsed-dose-rate Brachytherapy
• Systemic Radiotherapy
• Intravenouos Radiotherapy
• Oral Radiotherapy
• Instillation Radiotherapy

By End-User

• Hospitals
• Independent Radiotherapy Centers

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Research Methodology

The research methodology adopted by analysts for compiling the global radiation therapy market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global radiation therapy market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Radiation Therapy Market 

5.1. COVID-19 Landscape: Radiation Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Radiation Therapy Market, By Type

8.1. Radiation Therapy Market, by Type, 2022-2030

8.1.1. Product

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Service

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Radiation Therapy Market, By Technology

9.1. Radiation Therapy Market, by Technology, 2022-2030

9.1.1. External Beam Radiotherapy

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Convnetial Cobalt-60 Teletherapy Units

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Particle Therapy Systems

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Internal Beam Radiotherapy/Brachytherapy

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Systemic Radiotherapy

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Radiation Therapy Market, By Application 

10.1. Radiation Therapy Market, by Application, 2022-2030

10.1.1. External Beam Radiotherapy

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Internal Beam Radiotherapy/Brachytherapy

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Radiation Therapy Market, By Procedure

11.1. Radiation Therapy Market, by Procedure, 2022-2030

11.1.1. External Beam Radiotherapy

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Internal Beam Radiotherapy/Brachytherapy

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Systemic Radiotherapy

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Intravenouos Radiotherapy

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Oral Radiotherapy

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Instillation Radiotherapy

11.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Radiation Therapy Market, By End-User

12.1. Radiation Therapy Market, by End-User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Independent Radiotherapy Centers

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Radiation Therapy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.4. Market Revenue and Forecast, by Procedure (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.7. Market Revenue and Forecast, by Procedure (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.10. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.11. Market Revenue and Forecast, by End-User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.13. Market Revenue and Forecast, by End-User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.15. Market Revenue and Forecast, by End-User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.7. Market Revenue and Forecast, by End-User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.9. Market Revenue and Forecast, by End-User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.7. Market Revenue and Forecast, by End-User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.9. Market Revenue and Forecast, by End-User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.7. Market Revenue and Forecast, by End-User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 14. Company Profiles

14.1. Nordion Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Siemens healthcare

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Mevion medical system, Inc

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Isoray, Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Icad, Inc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton Dickinson and Company

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Ion Beam Appications SA

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Elekta AB

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Eckert & Zeigler Group

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Accuray

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com